OSE Immunotherapeutics soars on partnership rumors
OSE Immunotherapeutics shares jumped 15% in a single session in Paris.
Published 2sem1 sourceImportantupdated 2sem
Lire en français
≈ 16s
The fact
Rumors suggest a potential deal with a major U.S. pharmaceutical company.
The biotech firm has not confirmed the rumors, but trading volume tripled.
Click the link to read an article on the topic: